Ok Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 11, 2020 at 03:39 pm EST
Share
OK Biotech Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 341.932 million compared to TWD 290.936 million a year ago. Operating income was TWD 21.234 million compared to TWD 25.110 million a year ago. Net income was TWD 26.388 million compared to TWD 38.263 million a year ago. Basic earnings per share was TWD 0.3 compared to TWD 0.52 a year ago. Diluted earnings per share was TWD 0.29 compared to TWD 0.47 a year ago. For the nine months, sales was TWD 1,032.020 million compared to TWD 866.141 million a year ago. Operating income was TWD 80.935 million compared to TWD 71.263 million a year ago. Net income was TWD 94.065 million compared to TWD 92.494 million a year ago. Basic earnings per share was TWD 1.17 compared to TWD 1.27 a year ago. Diluted earnings per share was TWD 1.1 compared to TWD 1.11 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
